“Antiproliferative activity of synthesized dibutyltin(IV) hydroxybenzoate derivatives against A549, MCF-7, and HeLa human cancer cells”, J. Nig. Soc. Phys. Sci., vol. 8, no. 4, p. 3552, Sep. 2026, doi: 10.46481/jnsps.2026.3552.